To address situations where patients may be unaware that their blood sugar is falling to critical levels, MIT engineers have developed an implantable device that holds a supply of glucagon beneath the skin. This device can be activated to release the hormone automatically when glucose drops too low.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
